Palisade Bio CEO, CFO, and Director Buy 40,000 Shares
ByAinvest
Friday, Sep 29, 2023 9:26 am ET1min read
Palisade Bio, Inc. (PALI) has announced that its Chief Executive Officer, Chief Financial Officer, and Director, Finley John David, has purchased 15,000 shares of the company's stock at a price of $0.54 per share on September 27, 2023. Additionally, the company's Director, Donald Allen Williams, has purchased 20,000 shares at the same price on the same date. These purchases demonstrate the confidence that the company's leadership has in its future prospects and are a positive development for the company and its shareholders.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet